{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T14:02:31Z","timestamp":1781445751332,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,10]],"date-time":"2012-09-10T00:00:00Z","timestamp":1347235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To monitor the adverse drug reactions (ADRs) caused by antihypertensive medicines prescribed in a university teaching hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The present work was an open, non-comparative, observational study conducted on hypertensive patients attending the Medicine OPD of Majeedia Hospital, Jamia Hamdard, New Delhi, India by conducting patient interviews and recording the data on ADR monitoring form as recommended by Central Drugs Standard Control Organization (CDSCO), Government of India.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 21 adverse drug reactions were observed in 192 hypertensive patients. Incidence of adverse drug reactions was found to be higher in patients more than 40\u2009years in age, and females experienced more ADRs (n = 14, 7.29%) than males, 7 (3.64%). Combination therapy was associated with more number of adverse drug reactions (66.7%) as against monotherapy (33.3%). Calcium channel blockers were found to be the most frequently associated drugs with adverse drug reactions (n = 7), followed by diuretics (n = 5), and \u03b2-blockers (n = 4). Among individual drugs, amlodipine was found to be the commonest drug associated with adverse drug reactions (n = 7), followed by torasemide (n = 3). Adverse drug reactions associated with central nervous system were found to be the most frequent (42.8%) followed by musculo-skeletal complaints (23.8%) and gastro-intestinal disorders (14.3%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The present pharmacovigilance study represents the adverse drug reaction profile of the antihypertensive medicines prescribed in our university teaching hospital. The above findings would be useful for physicians in rational prescribing. Calcium channel blockers were found to be the most frequently associated drugs with adverse drug reactions.<\/jats:p><\/jats:sec>","DOI":"10.1186\/2008-2231-20-34","type":"journal-article","created":{"date-parts":[[2012,9,10]],"date-time":"2012-09-10T17:01:52Z","timestamp":1347296512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Monitoring of adverse drug reactions associated with antihypertensive medicines at a university teaching hospital in New Delhi"],"prefix":"10.1186","volume":"20","author":[{"given":"Fowad","family":"Khurshid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Aqil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shamshir","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna K","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,10]]},"reference":[{"key":"20_CR1","first-page":"6","volume":"48","author":"L Homsted","year":"2000","unstructured":"Homsted L: Institute of Medicine report: to err is human: building a safer health care system. Fla Nurse. 2000, 48: 6-","journal-title":"Fla Nurse"},{"key":"20_CR2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/009127000004001001","volume":"40","author":"American College of Clinical Pharmacology response to the Institute of Medicine report American College of Clinical Pharmacology response to the Institute of Medicine report \u201cTo err is human: building a safer health system\u201d","year":"2000","unstructured":"American College of Clinical Pharmacology response to the Institute of Medicine report American College of Clinical Pharmacology response to the Institute of Medicine report \u201cTo err is human: building a safer health system\u201d: The Public Policy Committee. J Clin Pharmacol. 2000, 40: 1075-1078.","journal-title":"J Clin Pharmacol"},{"key":"20_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01974520-200110000-00001","volume":"18","author":"ME Stefl","year":"2001","unstructured":"Stefl ME: To Err is Human: Building a Safer Health System in 1999. Front Health Serv Manage. 2001, 18: 1-2.","journal-title":"Front Health Serv Manage"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1001\/jama.1964.03060370032007","volume":"188","author":"LE Cluff","year":"1964","unstructured":"Cluff LE, Thornton GF, Seidl LG: Studies on the Epidemiology of Adverse Drug Reactions. I. Methods of Surveillance. JAMA. 1964, 188: 976-983. 10.1001\/jama.1964.03060370032007.","journal-title":"JAMA"},{"key":"20_CR5","first-page":"1450","volume":"97","author":"RI Ogilvie","year":"1967","unstructured":"Ogilvie RI, Ruedy J: Adverse drug reactions during hospitalization. Can Med Assoc J. 1967, 97: 1450-1457.","journal-title":"Can Med Assoc J"},{"key":"20_CR6","first-page":"1","volume":"498","author":"International drug monitoring: the role of national centres","year":"1972","unstructured":"International drug monitoring: the role of national centres: Report of a WHO meeting. World Health Organ Tech Rep Ser. 1972, 498: 1-25.","journal-title":"World Health Organ Tech Rep Ser"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1001\/jama.1993.03500210065033","volume":"269","author":"DA Kessler","year":"1993","unstructured":"Kessler DA: Introduction: Med Watch using FDA form 3500, a new approach to reporting medication and device adverse effects and products problem. JAMA. 1993, 269: 2765-2768. 10.1001\/jama.1993.03500210065033.","journal-title":"JAMA"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998, 279: 1200-1205. 10.1001\/jama.279.15.1200.","journal-title":"JAMA"},{"key":"20_CR9","first-page":"16","volume":"16","author":"S Sriram","year":"2011","unstructured":"Sriram S, Ghasemi A, Ramasamy R, Devi M, Balasubramanian R, Ravi TK: Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci. 2011, 16: 16-25.","journal-title":"J Res Med Sci"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2125.2007.02993.x","volume":"65","author":"R Arulmani","year":"2008","unstructured":"Arulmani R, Rajendran SD, Suresh B: Adverse drug reaction monitoring in a secondary care hospital in South India. Br J Clin Pharmacol. 2008, 65: 210-216. 10.1111\/j.1365-2125.2007.02993.x.","journal-title":"Br J Clin Pharmacol"},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/pds.871","volume":"12","author":"M Ramesh","year":"2003","unstructured":"Ramesh M, Pandit J, Parthasarathi G: Adverse drug reactions in a south Indian hospital\u2013their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003, 12: 687-692. 10.1002\/pds.871.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"20_CR12","first-page":"27","volume":"5","author":"V Dhikav","year":"2004","unstructured":"Dhikav V, Singh S, Anand KS: Adverse drug reaction monitoring in India. JIACM. 2004, 5: 27-33.","journal-title":"JIACM"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30: 239-245. 10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"},{"key":"20_CR14","first-page":"46","volume":"5","author":"H Sharma","year":"2007","unstructured":"Sharma H, Aqil M, Imam F, Alam MS, Kapur P, Pillai KK: A pharmacovigilance study in the department of medicine of a university teaching hospital. Pharm Pract. 2007, 5: 46-49.","journal-title":"Pharm Pract"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/080370599439580","volume":"8","author":"H Olsen","year":"1999","unstructured":"Olsen H, Klemetsrud T, Stokke HP, Tretli S, Westheim A: Adverse drug reactions in current antihypertensive therapy: a general practice survey of 2586 patients in Norway. Blood Press. 1999, 8: 94-101. 10.1080\/080370599438266.","journal-title":"Blood Press"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1211\/ijpp.14.4.0012","volume":"14","author":"M Aqil","year":"2006","unstructured":"Aqil M, Imam F, Hussain A, Alam MS, Kapur P, Pillai KK: A pharmacovigilance study for monitoring adverse drug reactions with antihypertensive agents at a South Delhi hospital. Int J Pharm Pract. 2006, 14: 311-313. 10.1211\/ijpp.14.4.0012.","journal-title":"Int J Pharm Pract"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4103\/0250-474X.56018","volume":"71","author":"A Hussain","year":"2009","unstructured":"Hussain A, Aqil M, Alam MS, Khan MR, Kapur P, Pillai KK: A pharmacovigilance study of antihypertensive medicines at a South delhi hospital. Indian J Pharm Sci. 2009, 71: 338-341. 10.4103\/0250-474X.56018.","journal-title":"Indian J Pharm Sci"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/pds.1916","volume":"19","author":"N Mohebbi","year":"2010","unstructured":"Mohebbi N, Shalviri G, Salarifar M, Salamzadeh J, Gholami K: Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients. Pharmacoepidemiol Drug Saf. 2010, 19: 889-894. 10.1002\/pds.1916.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","volume":"21","author":"Guidelines Committee","year":"2003","unstructured":"Guidelines Committee: European Society of Hypertension- European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003, 21: 1011-1053.","journal-title":"J Hypertens"},{"key":"20_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00004872-200401000-00003","volume":"22","author":"PM Kearney","year":"2004","unstructured":"Kearney PM, Whelton M, Reynolds K, Whelton PK, He J: Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004, 22: 11-19. 10.1097\/00004872-200401000-00003.","journal-title":"J Hypertens"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jama.1974.03230310023021","volume":"228","author":"GJ Caranasos","year":"1974","unstructured":"Caranasos GJ, Stewart RB, Cluff LE: Drug-induced illness leading to hospitalization. JAMA. 1974, 228: 713-717. 10.1001\/jama.1974.03230310023021.","journal-title":"JAMA"},{"key":"20_CR22","first-page":"814","volume":"66","author":"SC Basak","year":"2004","unstructured":"Basak SC, Ravi K, Manavalan R, Sahoo RK: A study of adverse drug reactions to antihypertensive drugs perceived by patients in a rural hospital. Ind J Pham Sci. 2004, 66: 814-818.","journal-title":"Ind J Pham Sci"},{"key":"20_CR23","first-page":"51","volume":"6","author":"K Gholami","year":"2008","unstructured":"Gholami K, Ziaie S, Shalviri G: Adverse drug reactions induced by cardiovascular drugs in outpatients. Pharm Pract. 2008, 6: 51-55.","journal-title":"Pharm Pract"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s002280100333","volume":"57","author":"S Malhotra","year":"2001","unstructured":"Malhotra S, Karan RS, Pandhi P, Jain S: Pattern of use and pharmacoeconomic impact of antihypertensive drugs in a north Indian referral hospital. Eur J Clin Pharmacol. 2001, 57: 535-540. 10.1007\/s002280100333.","journal-title":"Eur J Clin Pharmacol"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/080370599438383","volume":"8","author":"P Biston","year":"1999","unstructured":"Biston P, Melot C, Degaute JP, Clement D, Quoidbach A: Prolonged antihypertensive effect of amlodipine: a prospective double-blind randomized study. Blood Press. 1999, 8: 43-48. 10.1080\/080370599438383.","journal-title":"Blood Press"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/157488606775252610","volume":"1","author":"A Ferrari","year":"2006","unstructured":"Ferrari A: Headache: one of the most common and troublesome adverse reactions to drugs. Curr Drug Saf. 2006, 1: 43-58. 10.2174\/157488606775252610.","journal-title":"Curr Drug Saf"},{"key":"20_CR27","first-page":"141","volume":"40","author":"KS Woo","year":"1995","unstructured":"Woo KS, Nicholls MG: High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Br J Clin Pharmacol. 1995, 40: 141-144.","journal-title":"Br J Clin Pharmacol"},{"key":"20_CR28","first-page":"504","volume":"5","author":"N Jha","year":"2007","unstructured":"Jha N, Bajracharya O, Namgyal T: Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley. Kathmandu Univ Med J. 2007, 5: 504-510.","journal-title":"Kathmandu Univ Med J"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1345\/1542-6270(2000)034<1373:CAEIOA>2.0.CO;2","volume":"34","author":"DC Suh","year":"2000","unstructured":"Suh DC, Woodall BS, Shin SK: Hermes-De Santis ER. Clinical and economic impact of adverse drug reactions in hospitalized patients. Ann Pharmacother. 2000, 34: 1373-1379.","journal-title":"Ann Pharmacother"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2008-2231-20-34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2008-2231-20-34\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2008-2231-20-34.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T02:54:25Z","timestamp":1714359265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/2008-2231-20-34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,10]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1186\/2008-2231-20-34","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,10]]},"assertion":[{"value":"3 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"34"}}